ID

44699

Description

Rituximab-HCVAD in Patients With B-Cell Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00290498

Link

https://clinicaltrials.gov/show/NCT00290498

Keywords

  1. 4/25/17 4/25/17 -
  2. 9/27/21 9/27/21 -
Uploaded on

September 27, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma NCT00290498

Eligibility Lymphoma NCT00290498

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00290498
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. confirmed diagnosis of previously untreated large b-cell non hodgkin's, large cell lymphoma and b-cell with high grade features. other aggressive lymphomas such as primary mediastinal large b-cell lymphomas will be also allowed to be included.
Description

Diffuse Large B-Cell Lymphoma | Reticulosarcoma | High grade B-cell lymphoma | Aggressive Lymphoma | Mediastinal Large B-Cell Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0079744
UMLS CUI [2]
C0024302
UMLS CUI [3]
C0456863
UMLS CUI [4]
C1332225
UMLS CUI [5]
C1292754
2. patients with performance status of 0-2 (zubrod scale).
Description

Zubrod Performance Status

Data type

boolean

Alias
UMLS CUI [1]
C3714786
3. serum bilirubin <1.5 mg/dl and serum creatinine < 2.0 mg/dl unless due to lymphoma; anc >1000/mm^3 and platelets >100,000/mm^3 unless due to lymphoma.
Description

Serum total bilirubin measurement | Creatinine measurement, serum | Serum creatinine measurement Due to Lymphoma | Absolute neutrophil count | Platelet Count measurement | Platelet Count measurement Due to Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201976
UMLS CUI [3,1]
C0201976
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C0024299
UMLS CUI [4]
C0948762
UMLS CUI [5]
C0032181
UMLS CUI [6,1]
C0032181
UMLS CUI [6,2]
C0678226
UMLS CUI [6,3]
C0024299
4. cardiac ejection fraction 50% or greater.
Description

Cardiac ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0232174
5. ages 16 - 60 years (due to the fact that chop-r is not studied enough in younger patients and is not considered standard of care).
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
6. patients must be willing to receive transfusions of blood products.
Description

Blood Transfusion Receive Willing

Data type

boolean

Alias
UMLS CUI [1,1]
C0005841
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C0600109
7. age adjusted international prognostic index score of 2 or more
Description

International Prognostic Index Age Adjusted

Data type

boolean

Alias
UMLS CUI [1,1]
C1512894
UMLS CUI [1,2]
C0001779
UMLS CUI [1,3]
C0456081
8. previous steroids are allowed (if used to relieve some symptoms such as svc, etc).
Description

Steroids | Superior Vena Cava Syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0038317
UMLS CUI [2]
C0038833
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. pregnancy (excluded due to the teratogenicity of the involved chemotherapy agents
Description

Pregnancy | Teratogenicity | Antineoplastic Agents

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0232910
UMLS CUI [3]
C0003392
2. positive hiv serology because of poor tolerance to this intense chemotherapy regimen
Description

HIV Seropositivity | Tolerance Poor Chemotherapy High dose

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2,1]
C0034537
UMLS CUI [2,2]
C0542537
UMLS CUI [2,3]
C0392920
UMLS CUI [2,4]
C0444956
3. burkitt's lymphomas, and mantle cell lymphoma, transformed follicular center cell lymphoma, follicular grade iii.
Description

Burkitt Lymphoma | Mantle cell lymphoma | Follicular center cell lymphoma transformed | Follicular Lymphoma Grade

Data type

boolean

Alias
UMLS CUI [1]
C0006413
UMLS CUI [2]
C0334634
UMLS CUI [3,1]
C0474849
UMLS CUI [3,2]
C1510411
UMLS CUI [4,1]
C0024301
UMLS CUI [4,2]
C0441800
4. any clinical or cytological diagnosis of cns involvement
Description

Central Nervous System Involvement

Data type

boolean

Alias
UMLS CUI [1]
C4050309
5. any co-morbid medical, such as child's class c liver cirrhosis, end-stage renal disease, and symptomatic congestive heart failure, or psychiatric illnesses that preclude treatment with intense dose chemotherapy as determined by the primary investigator.
Description

Comorbidity Excludes Chemotherapy High dose | Liver Cirrhosis Child-Pugh Classification | Kidney Failure, Chronic | Symptomatic congestive heart failure | Mental disorders

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0392920
UMLS CUI [1,4]
C0444956
UMLS CUI [2,1]
C0023890
UMLS CUI [2,2]
C4050412
UMLS CUI [3]
C0022661
UMLS CUI [4]
C0742758
UMLS CUI [5]
C0004936
6. concurrent or previous malignancy whose prognosis is poor (< 90% probability of survival at 5 years)
Description

Malignant Neoplasm Prognosis bad | Survival Probability Percentage

Data type

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0278252
UMLS CUI [2,1]
C0038952
UMLS CUI [2,2]
C0033204
UMLS CUI [2,3]
C0439165
7. active hepatitis b or c. chronic carriers for hepatitis b will be excluded.
Description

Hepatitis B | Hepatitis C | Hepatitis B, Chronic

Data type

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
UMLS CUI [3]
C0524909

Similar models

Eligibility Lymphoma NCT00290498

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00290498
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diffuse Large B-Cell Lymphoma | Reticulosarcoma | High grade B-cell lymphoma | Aggressive Lymphoma | Mediastinal Large B-Cell Lymphoma
Item
1. confirmed diagnosis of previously untreated large b-cell non hodgkin's, large cell lymphoma and b-cell with high grade features. other aggressive lymphomas such as primary mediastinal large b-cell lymphomas will be also allowed to be included.
boolean
C0079744 (UMLS CUI [1])
C0024302 (UMLS CUI [2])
C0456863 (UMLS CUI [3])
C1332225 (UMLS CUI [4])
C1292754 (UMLS CUI [5])
Zubrod Performance Status
Item
2. patients with performance status of 0-2 (zubrod scale).
boolean
C3714786 (UMLS CUI [1])
Serum total bilirubin measurement | Creatinine measurement, serum | Serum creatinine measurement Due to Lymphoma | Absolute neutrophil count | Platelet Count measurement | Platelet Count measurement Due to Lymphoma
Item
3. serum bilirubin <1.5 mg/dl and serum creatinine < 2.0 mg/dl unless due to lymphoma; anc >1000/mm^3 and platelets >100,000/mm^3 unless due to lymphoma.
boolean
C1278039 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0201976 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C0024299 (UMLS CUI [3,3])
C0948762 (UMLS CUI [4])
C0032181 (UMLS CUI [5])
C0032181 (UMLS CUI [6,1])
C0678226 (UMLS CUI [6,2])
C0024299 (UMLS CUI [6,3])
Cardiac ejection fraction
Item
4. cardiac ejection fraction 50% or greater.
boolean
C0232174 (UMLS CUI [1])
Age
Item
5. ages 16 - 60 years (due to the fact that chop-r is not studied enough in younger patients and is not considered standard of care).
boolean
C0001779 (UMLS CUI [1])
Blood Transfusion Receive Willing
Item
6. patients must be willing to receive transfusions of blood products.
boolean
C0005841 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
International Prognostic Index Age Adjusted
Item
7. age adjusted international prognostic index score of 2 or more
boolean
C1512894 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
C0456081 (UMLS CUI [1,3])
Steroids | Superior Vena Cava Syndrome
Item
8. previous steroids are allowed (if used to relieve some symptoms such as svc, etc).
boolean
C0038317 (UMLS CUI [1])
C0038833 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Teratogenicity | Antineoplastic Agents
Item
1. pregnancy (excluded due to the teratogenicity of the involved chemotherapy agents
boolean
C0032961 (UMLS CUI [1])
C0232910 (UMLS CUI [2])
C0003392 (UMLS CUI [3])
HIV Seropositivity | Tolerance Poor Chemotherapy High dose
Item
2. positive hiv serology because of poor tolerance to this intense chemotherapy regimen
boolean
C0019699 (UMLS CUI [1])
C0034537 (UMLS CUI [2,1])
C0542537 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])
C0444956 (UMLS CUI [2,4])
Burkitt Lymphoma | Mantle cell lymphoma | Follicular center cell lymphoma transformed | Follicular Lymphoma Grade
Item
3. burkitt's lymphomas, and mantle cell lymphoma, transformed follicular center cell lymphoma, follicular grade iii.
boolean
C0006413 (UMLS CUI [1])
C0334634 (UMLS CUI [2])
C0474849 (UMLS CUI [3,1])
C1510411 (UMLS CUI [3,2])
C0024301 (UMLS CUI [4,1])
C0441800 (UMLS CUI [4,2])
Central Nervous System Involvement
Item
4. any clinical or cytological diagnosis of cns involvement
boolean
C4050309 (UMLS CUI [1])
Comorbidity Excludes Chemotherapy High dose | Liver Cirrhosis Child-Pugh Classification | Kidney Failure, Chronic | Symptomatic congestive heart failure | Mental disorders
Item
5. any co-morbid medical, such as child's class c liver cirrhosis, end-stage renal disease, and symptomatic congestive heart failure, or psychiatric illnesses that preclude treatment with intense dose chemotherapy as determined by the primary investigator.
boolean
C0009488 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C0444956 (UMLS CUI [1,4])
C0023890 (UMLS CUI [2,1])
C4050412 (UMLS CUI [2,2])
C0022661 (UMLS CUI [3])
C0742758 (UMLS CUI [4])
C0004936 (UMLS CUI [5])
Malignant Neoplasm Prognosis bad | Survival Probability Percentage
Item
6. concurrent or previous malignancy whose prognosis is poor (< 90% probability of survival at 5 years)
boolean
C0006826 (UMLS CUI [1,1])
C0278252 (UMLS CUI [1,2])
C0038952 (UMLS CUI [2,1])
C0033204 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Hepatitis B | Hepatitis C | Hepatitis B, Chronic
Item
7. active hepatitis b or c. chronic carriers for hepatitis b will be excluded.
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0524909 (UMLS CUI [3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial